Job was saved successfully.
Job was removed from Saved Jobs.

Job Details

Executive Director Cell & Gene Therapy Modality Team Head


Executive Director


East Hanover, New Jersey, United States

1 purpose! Novartis expands its early development and innovative CAR-T cell therapy manufacturing capabilities in its newly launched Center of Excellence, located in the East Hanover, NJ campus. Our therapies are being developed as transformative treatments with life-saving potential for various B cell malignancies and other oncological diseases. We look to be bold with purpose, as we reimagine medicine and lead the way in advancing scientific breakthroughs for patients.<br><br>The Executive Director TRD (Technical Research & Development) CGT (Cell & Gene Therapy) Modality Team Head will lead a team of Technical Project Leaders and thereby, responsible for the technical development activities of the assigned Modality Area and related Development Unit (DU) and/or Disease Area NIBR (DA) portfolios with accountability as defined for each Modality Area.<br><br>**This opportunity has the ability to be based in Cambridge MA or Durham NC, however East Hanover NJ is highly preferred.**<br><br>Your responsibilities will include, but are not limited to:<br><br>• As an extended member of the NIBR DADB and/or GDD DULT and BD&L identify strategic opportunities and shape and optimize TRD’s contribution to the business and to the implementation of the overall strategy in close collaboration with the TRD TPPM TAH. Play an active role in setting cross-functional goals. As a recognized distinguished R&D leader, bring technical expertise to these boards and constructively challenge them, as needed. Ensure alignment with internal and external partners and ensure implementation of the leadership team and the boards’ decisions within TRD CGT. Create active and effective partnerships with key stakeholders from NIBR, GDD, NTO and Commercial and TRD-LFs, manage expectations and resolve issues. Influence portfolio assessment, prioritization and forecasting.<br>• As a member of the CGT Technical Project Board influence critical project reviews and decision making. Ensure the DU’s/DA’s aspects are adequately considered during decision making.<br>• As a member of the CGT PM LT, provide leadership and direction to the organization. Act as deputy Global Head CGT PM. Lead or be a key member for issue resolution teams (“tiger teams”) or global, cross-functional workstreams.<br>• Ensure that project objectives are in line with DU’s/DA’s objectives and fully accountable to achieve goals, strategic directives and that targeted project milestones are met within agreed upon timelines.<br>• Ensure excellence in CMC strategy (competitive and sound technical development strategies) and in execution of project plans through critical reviews, mentoring and coaching of TRD Technical Project Leaders (TPL) and TRD sub teams.<br>• Ensure TRD CGT’s deliverables are supporting partners (NIRB, GDD, NTO, Commercial) needs and prepare TRD CGT for future trends and challenges.<br>• Ensure alignment on project objectives and deliverables within TRD CGT through TRD CGT Line function Heads, RA-CMC Line Function Heads and TRD TPLs as well as, if needed, through other TPB CGT-members and TRD Line Functions.<br>• Ensure alignment of TRD CGT’s technology strategies with the strategies of NIBR DA, GDD DU, NTO and Commercial. <br>• Act as operational manager and coach to a global group of TPLs working on assigned projects. Ensure that best-project management practice and risk management are applied to the projects and that innovative, competitive technologies are utilized in the development products in support of customized therapies.<br>• Serve as a role model, foster a culture of high performance and trust, i.e. a culture based on constructive styles and champion the spirit of servant leadership.<br>• Work with TRD BD&L External Business Operations on DU or DA in-licensing strategies/partnerships; influence asset evaluation (PCD, PE, cDD), review results of evaluations (e.g. 1pager, CMC DD report) and align the TRD message to DULT/FLT or DADB; prepare transition from negotiation to integration of project – as per actual assignments. <br>• Act as a Joint Steering (Development) Committee member of in-licensing projects in support of alliance management - as per actual need.<br>• Ensure – in close collaboration with TPL - high quality communication and project information flow to TRD in preparation for management boards.<br>• Influence/persuade and work according to appropriate SOPs, GLP/GMP, QM, HSE, ISEC, Novartis & regulatory Guidelines.<br>• Create “centers of excellence” around the respective modality and drug development paradigms (cell and gene therapy, respectively) whilst ensuring that the two Modality Teams are fully engaged into cross-fertilization and exchange of Learning Opportunities<br><br>The pay range for this position at commencement of employment is expected to be between $222,400 and $333,600 year; however, base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. The total compensation package for this position may also include other elements, including a sign-on bonus, restricted stock units, and discretionary awards in addition to a full range of medical, financial, and/or other benefits (including 401(k) eligibility and various paid time off benefits, such as vacation, sick time, and parental leave), dependent on the position offered. Details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.<br><br><br>[#video#{#400,300#}#/video#]